Cited by 1,617HIV/AIDS Research and InterventionsHIV-related health complications and treatmentsHIV Research and Treatment

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Open access

Kuller, Lewis H, Tracy, Russell, Belloso, Waldo, Wit, Stephane De, Drummond, Fraser, Lane, H. Clifford, Ledergerber, Bruno, Lundgren, Jens, Neuhaus, Jacqueline, Nixon, Daniel, Paton, Nicholas I, Neaton, James D, for the INSIGHT SMART Study Group·2008·PLoS Medicine

DOI 10.1371/journal.pmed.0050203PMC PMC2570418

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: In the Strategies for Management of Anti-Retroviral Therapy trial, all-cause mortality was higher for participants randomized to intermittent, CD4-guided antiretroviral treatment (ART) (drug conservation [DC]) than continuous ART (viral suppression [VS]).We hypothesized that increased HIV-RNA levels following ART interruption induced activation of tissue factor pathways, thrombosis, and fibrinolysis. METHODS AND FINDINGS: Stored samples were used to measure six biomarkers: high sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), amyloid A, amyloid P, D-dimer, and prothrombin fragment 1+2. Two studies were conducted: (1) a nested case-control study for studying biomarker associations with mortality, and (2) a study to compare DC and VS participants for biomarker changes. For (1), markers were determined at study entry and before death (latest level) for 85 deaths and for two controls (n = 170) matched on country, age, sex, and date of randomization. Odds ratios (ORs) were estimated with logistic regression. For each biomarker, each of the three upper quartiles was compared to the lowest quartile. For (2), the biomarkers were assessed for 249 DC and 250 VS participants at study entry and 1 mo following randomization. Higher levels of hsCRP, IL-6, and D-dimer at study entry were significantly associated with an increased risk of all-cause mortality. Unadjusted ORs (highest versus lowest quartile) were 2.0 (95% confidence interval [CI], 1.0-4.1; p = 0.05), 8.3 (95% CI, 3.3-20.8; p < 0.0001), and 12.4 (95% CI, 4.2-37.0; p < 0.0001), respectively. Associations were significant after adjustment, when the DC and VS groups were analyzed separately, and when latest levels were assessed. IL-6 and D-dimer increased at 1 mo by 30% and 16% in the DC group and by 0% and 5% in the VS group (p < 0.0001 for treatment difference for both biomarkers); increases in the DC group were related to HIV-RNA levels at 1 mo (p < 0.0001). In an expanded case-control analysis (four controls per case), the OR (DC/VS) for mortality was reduced from 1.8 (95% CI, 1.1-3.1; p = 0.02) to 1.5 (95% CI, 0.8-2.8) and 1.4 (95% CI, 0.8-2.5) after adjustment for latest levels of IL-6 and D-dimer, respectively. CONCLUSIONS: IL-6 and D-dimer were strongly related to all-cause mortality. Interrupting ART may further increase the risk of death by raising IL-6 and D-dimer levels. Therapies that reduce the inflammatory response to HIV and decrease IL-6 and D-dimer levels may warrant investigation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.0050203

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Exploratory Data Analysis
David, F. N., & Tukey, J. W. (1977) · Biometrics · doi:10.2307/2529486 · Cited by 12,707
A simulation study of the number of events per variable in logistic regression analysis
Peduzzi, P., Concato, J., Kemper, E., Holford, T. R., & Feinstein, A. R. (1996) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00236-3 · Cited by 9,655
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
CD4+ Count–Guided Interruption of Antiretroviral Treatment
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,250
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488
Exploratory Data Analysis.
Birch, J. B., & Tukey, J. W. (1978) · Journal of the American Statistical Association · doi:10.2307/2286300 · Cited by 1,465
Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study
Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,098
Serum Amyloid A as a Predictor of Coronary Artery Disease and Cardiovascular Outcome in Women
Johnson, B. D., Kip, K. E., Marroquin, O. C., Ridker, P. M., Kelsey, S. F., Shaw, L. J., Pepine, C. J., Sharaf, B. L., Merz, C. N. B., Sopko, G. S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000115516.54550.b1 · Cited by 417
Problems due to Small Samples and Sparse Data in Conditional Logistic Regression Analysis
Greenland, S., Schwartzbaum, J., & Finkle, W. D. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010240 · Cited by 367

Flagged first, then by citations

Show all 42 references

1 of the 42 references couldn’t be matched to a known paper.

Research works printed but not linked: 38

De Larrangas, 2003, Blood Coagul Fibrinolysis, 14, 15
Torriani, 2008, J Am Coll Cardiol, 52, 569
Solages, 2006, Clin Infect Dis, 42, 1325
Lekakis, 2007, Euro Heart J (Suppl 1), 28, P2870
Wolf, 2002, J Infect Dis, 185, 456
Aziz, 1998, Clin Diagn Lab Immunol, 5, 755
Dolan, 2006, J Acquir Immune Defic Syndr, 39, 44
Lederman, 2000, AIDS, 14, 951
Lau, 2006, Arch Intern Med, 166, 64
Lifson, 2008, HIV Clin Trials, 9, 177
Sakkinen, 1999, Am J Epidemiol, 149, 261
Kuller, 1996, Am J Epidemiol, 144, 537
Johnson, 2004, Circulation, 109, 726
Harris, 1999, Am J Med, 106, 506
Ridker, 2000, Circulation, 101, 1767
Jenny, 2007, Arterioscler Thromb Vasc Biol, 27, 352
Danesh, 1999, Eur Heart J, 20, 954
Folsom, 2001, Thromb Haemost, 86, 366
Cushman, 1999, Arterioscler Thromb Vasc Biol, 19, 493
Danesh, 2001, Circulation, 103, 2323
Kooperberg, 2007, PLoS Clin Trials, 2
Cohen, 2003, Am J Med, 114, 180
Smith, 2005, Circulation, 112, 3080
Zakai, 2007, J Thromb Haemost, 5, 1128
Sasieni, 1992, Stat Med, 11, 617
Greenland, 2000, Am J Epidemiol, 151, 531
Peduzzi, 1996, J Clin Epidemiol, 49, 1373
Lowe, 2005, Semin Vasc Med, 5, 387
Lau, 2007, J Acquir Immune Defic Syndr, 44, 179
Shorr, 2002, CHEST, 121, 1262
Maldarelli, 2007, PLoS Pathog, 3, 484
Birdsall, 2002, AIDS, 16, 5
Brenchley, 2006, Nature Med, 12, 1365
Derhaschnig, 2004, Crit Care Med, 32, 1136
Boos, 2007, Am J Cardiol, 100, 986
Li, 2004, J Infect Dis, 189, 572
Decrion, 2005, Curr HIV Res, 3, 243
van Gorp, 1999, J Infect Dis, 180, 176

Sorted by citations

Items 301–400 of 1,000

Aging, Health, and Quality of Life for Older People Living With HIV in Sub-Saharan Africa: A Review and Proposed Conceptual Framework
Siedner, M. J. (2017) · Journal of Aging and Health · doi:10.1177/0898264317724549 · Cited by 68
Discordant Immune Response with Antiretroviral Therapy in HIV-1: A Systematic Review of Clinical Outcomes
Kelly, C., Gaskell, K. M., Richardson, M., Klein, N. J., Garner, P., & MacPherson, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156099 · Cited by 71
Persistent low-Level viremia in persons living with HIV undertreatment: An unresolved status
Crespo‐Bermejo, C., de Arellano, E. R., Lara‐Aguilar, V., Valle‐Millares, D., Gómez-Lus, M. L., Madrid, R., Martín‐Carbonero, L., & Briz, V. (2021) · Virulence · doi:10.1080/21505594.2021.2004743 · Cited by 69
Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV ‐infected children
Miller, T., Borkowsky, W., DiMeglio, L. A., Dooley, L. B., Geffner, M. E., Hazra, R., McFarland, E., Mendez, A. J., Patel, K., Siberry, G. K., et al. (2011) · HIV Medicine · doi:10.1111/j.1468-1293.2011.00970.x · Cited by 65
Markers of atherosclerosis and inflammation and mortality in patients with HIV infection
Mangili, A., Polak, J. F., Quach, L., Gerrior, J., & WANKE, C. A. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.11.013 · Cited by 66
Cardiovascular implications of HIV-induced dyslipidemia
Giannarelli, C., Klein, R. S., & Badimón, J. J. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.003 · Cited by 65
Epstein-Barr Virus load and immune activation in Human Immunodeficiency Virus type 1-infected patients
Petrara, M. R., Cattelan, A. M., Zanchetta, M., Sasset, L., Freguja, R., Gianesin, K., Cecchetto, M. G., Carmona, F., & Rossi, A. D. (2011) · Journal of Clinical Virology · doi:10.1016/j.jcv.2011.12.013 · Cited by 65
Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm
Ford, E. S., Puronen, C. E., & Sereti, I. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328329c68c · Cited by 70
Role of T‐Cell Dysfunction, Inflammation, and Coagulation in Microvascular Disease in HIV
Sinha, A., Ma, Y., Scherzer, R., Hur, S., Li, D., Ganz, P., Deeks, S. G., & Hsue, P. Y. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004243 · Cited by 68
Associations of Inflammatory Markers With AIDS and Non-AIDS Clinical Events After Initiation of Antiretroviral Therapy
McComsey, G. A., Kitch, D. W., Sax, P. E., Tierney, C., Jahed, N. C., Melbourne, K. M., Ha, B., Brown, T. T., Bloom, A. A., Fedarko, N. S., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000437171.00504.41 · Cited by 64
Safety, Efficacy, and Pharmacokinetics of TBR-652, a CCR5/CCR2 Antagonist, in HIV-1–Infected, Treatment-Experienced, CCR5 Antagonist–Naive Subjects
Lalezari, J. P., Gathe, J., Brinson, C. C., Thompson, M., Cohen, C. J., DeJesus, E., Galindez, J., Ernst, J. A., Martin, D. E., & Palleja, S. M. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318213c2c0 · Cited by 64
The Biology of Atherosclerosis: General Paradigms and Distinct Pathogenic Mechanisms Among HIV-Infected Patients
Lo, J., & Plutzky, J. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis201 · Cited by 64
Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV Infection
Shive, C. L., Clagett, B. M., McCausland, M. R., Mudd, J. C., Funderburg, N., Freeman, M. L., Younes, S., Ferrari, B., Rodriguez, B. A., McComsey, G. A., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000913 · Cited by 66
Sex differences in HIV-1-mediated immunopathology
Ziegler, S. M., & Altfeld, M. A. (2016) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000237 · Cited by 64
A new era of antiretroviral drug toxicity
Calmy, A., Hirschel, B. J., Cooper, D. A., & Carr, A. D. (2008) · Antiviral Therapy · doi:10.1177/135965350901400203 · Cited by 64
Intestinal damage precedes mucosal immune dysfunction in SIV infection
Hensley‐McBain, T., Berard, A. R., Manuzak, J. A., Miller, C. J., Zevin, A. S., Polacino, P. S., Gile, J., Agricola, B. A., Cameron, M. J., Hu, S.-L., et al. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0032-5 · Cited by 63
Reduced sTWEAK and Increased sCD163 Levels in HIV-Infected Patients: Modulation by Antiretroviral Treatment, HIV Replication and HCV Co-Infection
Beltrán, L. M., Múñoz‐Hernández, R., Pablo-Bernal, R. S. D., Morillo, J. S. G., Egido, J., Leal Noval, M., Ferrando‐Martínez, S., Blanco‐Colio, L. M., Genebat, M., Villar, J. R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090541 · Cited by 63
Inflammation, Immune Activation, Immunosenescence, and Hormonal Biomarkers in the Frailty-Related Phenotype of Men with or at Risk for HIV
Erlandson, K. M., Ng, D. K., Jacobson, L. P., Margolick, J. B., Dobs, A. S., Palella, F. J., Lake, J. E., Bui, H., Kingsley, L., & Brown, T. T. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw523 · Cited by 65
Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling
Giron, L. B., Peluso, M. J., Ding, J., Kenny, G., Zilberstein, N., Koshy, J., Hong, K. Y., Rasmussen, H. E., Miller, G. E., Bishehsari, F., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.160989 · Cited by 67
Distinct intestinal microbial signatures linked to accelerated systemic and intestinal biological aging
Singh, S. T., Giron, L. B., Shaikh, M. W., Shankaran, S., Engen, P. A., Bogin, Z. R., Bambi, S. A., Goldman, A. R., Azevedo, J. L. L. C., Orgaz, L., et al. (2024) · Microbiome · doi:10.1186/s40168-024-01758-4 · Cited by 63
Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first‐line combination antiretroviral therapy
Hattab, S., Guiguet, M., Carcelain, G., Fourati, S., Guihot, A., Autran, B., Caby, F., Marcelin, A., Costagliola, D. G., & Katlama, C. (2015) · HIV Medicine · doi:10.1111/hiv.12257 · Cited by 63
Untreated HIV Infection and Large and Small Artery Elasticity
Baker, J. V., Duprez, D. A., Rapkin, J. S., Hullsiek, K. H., Quick, H. S., Grimm, R. H., Neaton, J. D., & Henry, K. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181b02e6a · Cited by 62
Relationships of pulmonary function, inflammation, and T-cell activation and senescence in an HIV-infected cohort
Fitzpatrick, M. E., Singh, V. K., Bertolet, M. H., Lucht, L. A., Kessinger, C. J., Michel, J. J., Logar, A., Weinman, R., McMahon, D. K., Norris, K. A., et al. (2014) · AIDS · doi:10.1097/qad.0000000000000471 · Cited by 62
Association of Arterial and Lymph Node Inflammation With Distinct Inflammatory Pathways in Human Immunodeficiency Virus Infection
Tawakol, A. A., Ishai, A., Li, D., Takx, R. A. P., Hur, S., Kaiser, Y., Pampaloni, M. H., Rupert, A. W., Hsu, D. C., Sereti, I., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.4728 · Cited by 63
Mechanisms of Cardiovascular Disease in the Setting of HIV Infection
Hsue, P. Y. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.12.024 · Cited by 64
Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study
Palella, F. J., Gange, S. J., Benning, L., Jacobson, L., Kaplan, R. C., Landay, A. L., Tracy, R. P., & Elion, R. (2010) · AIDS · doi:10.1097/qad.0b013e3283389dfa · Cited by 61
Effect of Statin Therapy in Reducing the Risk of Serious Non-AIDS-Defining Events and Nonaccidental Death
Overton, E. T., Kitch, D. W., Benson, C. A., Hunt, P. W., Stein, J. H., Smurzynski, M., Ribaudo, H. J., & Tebas, P. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit053 · Cited by 62
Biologic aging, frailty, and age-related disease in chronic HIV infection
Brothers, T. D., & Rockwood, K. J. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000070 · Cited by 62
Interleukin-6, High Sensitivity C-Reactive Protein, and the Development of Type 2 Diabetes Among HIV-Positive Patients Taking Antiretroviral Therapy
Dooko, C. B. A., Wit, S. D., Neuhaus, J., Palfreeman, A., Pepe, R., Pankow, J. S., & Neaton, J. D. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000354 · Cited by 63
HIV, Inflammation, and Calcium in Atherosclerosis
Shrestha, S., Irvin, M. R., Grünfeld, C., & Arnett, D. K. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302191 · Cited by 61
Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study
Hattab, S., Guihot, A., Guiguet, M., Fourati, S., Carcelain, G., Caby, F., Marcelin, A., Autran, B., Costagliola, D. G., & Katlama, C. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-122 · Cited by 63
Long-term persistence of transcriptionally active ‘defective’ HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapy
Singh, K., Natarajan, V., Dewar, R. L., Rupert, A. W., Badralmaa, Y., Zhai, T., Winchester, N., Scrimieri, F., Smith, M., Davis, I., et al. (2023) · AIDS · doi:10.1097/qad.0000000000003667 · Cited by 62
Potential Cardiovascular Disease Risk Markers Among HIV-Infected Women Initiating Antiretroviral Treatment
Kaplan, R. C., LANDAY, A. L., Hodis, H. N., Gange, S. J., Norris, P. J., Young, M., Anastos, K., Tien, P. C., Xue, X., Lazar, J., et al. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31825b03be · Cited by 60
Cardiovascular Risk-Factor Knowledge and Risk Perception Among HIV-Infected Adults
Cioe, P. A., Crawford, S. L., & Stein, M. D. (2013) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2013.07.006 · Cited by 60
Early Antiretroviral Therapy During Primary HIV-1 Infection Results in a Transient Reduction of the Viral Setpoint upon Treatment Interruption
von Wyl, V., Gianella, S., Fischer, M., Niederöst, B. P., Kuster, H., Battegay, M., Bernasconi, E., Cavassini, M. L., Rauch, A., Hirschel, B. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027463 · Cited by 60
Antiretroviral Therapy Reduces T-cell Activation and Immune Exhaustion Markers in Human Immunodeficiency Virus Controllers
Li, J. Z., Segal, F., Bosch, R. J., Lalama, C. M., Roberts‐Toler, C., Delagreverie, H. M., Getz, R., García‐Broncano, P., Kinslow, J. D., Tressler, R., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz442 · Cited by 60
Neutrophil extracellular trap production contributes to pathogenesis in SIV-infected nonhuman primates
Sivanandham, R., Brocca‐Cofano, E., Krampe, N. A., Falwell, E., Venkatraman, S. M. K., Ribeiro, R. M., Apetrei, C., & Pandrea, I. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99420 · Cited by 62
HIV-Related Metabolic Comorbidities in the Current ART Era
Warriner, A. H., Burkholder, G., & Overton, E. T. (2014) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2014.05.003 · Cited by 62
Reduced Inflammation and Lymphoid Tissue Immunopathology in Rhesus Macaques Receiving Anti–Tumor Necrosis Factor Treatment During Primary Simian Immunodeficiency Virus Infection
Tabb, B., Morcock, D. R., Trubey, C. M., Quiñones, O. A., Hao, X., Smedley, J. V., MacAllister, R., Piatak, M., Harris, L. D., Paiardini, M., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis643 · Cited by 59
Hematopoietic stem cell transplantation for HIV cure
Kuritzkes, D. R. (2016) · Journal of Clinical Investigation · doi:10.1172/jci80563 · Cited by 59
Metabolic and Renal Adverse Effects of Antiretroviral Therapy in HIV-infected Children and Adolescents
Fortuny, C., Deyà‐Martínez, À., Chiappini, E., Galli, L., de Martino, M., & Noguera‐Julián, A. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000663 · Cited by 59
The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry
Kulkarni, H. R., Marconi, V. C., He, W., Landrum, M. L., Okulicz, J. F., Delmar, J., Kazandjian, D. G., Castiblanco, J., Ahuja, S. S., Wright, E., et al. (2009) · Blood · doi:10.1182/blood-2009-04-215186 · Cited by 59
Innate Immune Responses and Rapid Control of Inflammation in African Green Monkeys Treated or Not with Interferon-Alpha during Primary SIVagm Infection
Jacquelin, B., Petitjean, G., Kunkel, D., Liovat, A.-S., Jochems, S. P., Rogers, K. A., Ploquin, M. J.-Y., Madec, Y., Barré‐Sinoussi, F., Dereuddre‐Bosquet, N., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004241 · Cited by 58
Risk of Cardiovascular Events and Blood Pressure Control in Hypertensive HIV-Infected Patients
Nüesch, R., Wáng, Q., Elzi, L., Bernasconi, E., Weber, R. K., Cavassini, M. L., Vernazza, P., Thurnheer, M. C., Calmy, A., Battegay, M., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182847cd0 · Cited by 58
Leukocyte Telomere Length in HIV-Infected and HIV-Exposed Uninfected Children: Shorter Telomeres with Uncontrolled HIV Viremia
Côté, H. C. F., Soudeyns, H., Thorne, A., Alimenti, A., Lamarre, V., Maan, E. J., Sattha, B., Singer, J., Lapointe, N., Money, D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039266 · Cited by 59
Dynamics of Immune Reconstitution and Activation Markers in HIV+ Treatment-Naïve Patients Treated with Raltegravir, Tenofovir Disoproxil Fumarate and Emtricitabine
Funderburg, N., Andrade, A. S., Chan, E. S., Rosenkranz, S. L., Lu, D., Clagett, B. M., Pilch-Cooper, H. A., Rodriguez, B. A., Feinberg, J., Daar, E. S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083514 · Cited by 58
Soluble Urokinase Plasminogen Activator Receptor Is Predictive of Non-AIDS Events During Antiretroviral Therapy–mediated Viral Suppression
Hoenigl, M., Moser, C., Funderburg, N., Bosch, R. J., Kantor, A., Zhang, Y., Eugen‐Olsen, J., Finkelman, M., Reiser, J., LANDAY, A. L., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy966 · Cited by 58
Reduction of inflammation and T cell activation after 6 months of cART initiation during acute, but not in early chronic HIV-1 infection
de Paula, H. H. S., Ferreira, A. C. G., Caetano, D. G., Delatorre, E. O., Teixeira, S. L. M., Coelho, L. E., João, E. G., de Andrade, M. M., Cardoso, S. W., Grinsztejn, B. G. J., et al. (2018) · Retrovirology · doi:10.1186/s12977-018-0458-6 · Cited by 59
Heightened inflammation is linked to carotid intima-media thickness and endothelial activation in HIV-infected children
Ross, A. C., O’Riordan, M. A., Storer, N. J., Dogra, V. S., & McComsey, G. A. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.04.008 · Cited by 57
Tumor Necrosis Factor α Is Associated With Viral Control and Early Disease Progression in Patients With HIV Type 1 Infection
Vaidya, S. A., Korner, C., Sirignano, M. N., Amero, M. A., Bazner, S., Rychert, J. A., Allen, T. M., Rosenberg, E. S., Bosch, R. J., & Altfeld, M. A. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu206 · Cited by 57
Morbidity in older HIV-infected patients: impact of long-term antiretroviral use.
Guaraldi, G., Prakash, M., Moecklinghoff, C., & Stellbrink, H. (2014) · PubMed · Cited by 58
D-Dimer Levels before HIV Seroconversion Remain Elevated Even after Viral Suppression and Are Associated with an Increased Risk of Non-AIDS Events
Freiberg, M. S., Bebu, I., Tracy, R. P., So‐Armah, K., Okulicz, J. F., Ganesan, A., Armstrong, A. W., O’Bryan, T. A., Rimland, D., Justice, A. C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152588 · Cited by 57
Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset
Ploquin, M. J.-Y., Madec, Y., Casrouge, A., Huot, N., Passaes, C., Lécuroux, C., Essat, A., Boufassa, F., Jacquelin, B., Jochems, S. P., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005774 · Cited by 57
Inflammation and Metabolic Complications in HIV
Bourgi, K., Wanjalla, C. N., & Koethe, J. R. (2018) · Current HIV/AIDS Reports · doi:10.1007/s11904-018-0411-2 · Cited by 56
Safety and Impact of Low-dose Methotrexate on Endothelial Function and Inflammation in Individuals With Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314
Hsue, P. Y., Ribaudo, H. J., Deeks, S. G., Bell, T. K., Ridker, P. M., Fichtenbaum, C. J., Daar, E. S., Havlir, D. V., Yeh, E., Tawakol, A. A., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy781 · Cited by 57
Safety, Tolerability, and Immunogenicity of Repeated Doses of DermaVir, a Candidate Therapeutic HIV Vaccine, in HIV-Infected Patients Receiving Combination Antiretroviral Therapy
Rodriguez, B. A., Asmuth, D. M., Matining, R. M., Spritzler, J., Jacobson, J. M., Mailliard, R. B., Li, X.-D., Martínez, A. I., Tenorio, A. R., Lori, F., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182a99590 · Cited by 56
Baseline Kidney Function as Predictor of Mortality and Kidney Disease Progression in HIV-Positive Patients
Ibrahim, F., Hamzah, L., Jones, R., Nitsch, D., Sabin, C. A., & Post, F. A. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.03.006 · Cited by 56
The paradox of the immune response in HIV infection: When inflammation becomes harmful
Ipp, H., & Zemlin, A. E. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.11.025 · Cited by 56
TNF- levels in HIV-infected patients after long-term suppressive cART persist as high as in elderly, HIV-uninfected subjects
Pablo-Bernal, R. S. D., Ruíz-Mateos, E., Rosado‐Sánchez, I., Domínguez-Molina, B., Alvarez-Rios, A. I., Carrillo‐Vico, A., de la Rosa, R., Delgado, J., Muñoz‐Fernández, M. Á., Leal, M., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku263 · Cited by 56
HIV Infection and Primary Prevention of Cardiovascular Disease: Lights and Shadows in the HAART Era
Ballocca, F., Gili, S., D’Ascenzo, F., Marra, W. G., Cannillo, M., Calcagno, A., Bonora, S., Flammer, A. J., Coppola, J., Moretti, C., et al. (2016) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2016.02.008 · Cited by 56
The Dual Role of Neutrophils in HIV Infection
Hensley‐McBain, T., & Klatt, N. R. (2018) · Current HIV/AIDS Reports · doi:10.1007/s11904-018-0370-7 · Cited by 84
Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV
Elion, R., Althoff, K. N., Zhang, J., Moore, R. D., Gange, S. J., Kitahata, M. M., Crane, H. M., Drozd, D. R., Stein, J. H., Klein, M. B., et al. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001642 · Cited by 56
Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection
Titanji, B. K., Gavegnano, C., Hsue, P. Y., Schinazi, R. F., & Marconi, V. C. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014873 · Cited by 56
Late‐Onset Asthma Predicts Cardiovascular Disease Events: The Wisconsin Sleep Cohort
Tattersall, M. C., Barnet, J. H., Korcarz, C. E., Hagen, E. W., Peppard, P. E., & Stein, J. H. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003448 · Cited by 55
Mortality Among Persons Entering HIV Care Compared With the General U.S. Population
Edwards, J. K., Cole, S. R., Breger, T. L., Rudolph, J. E., Filiatreau, L. M., Buchacz, K. A., Humes, E., Rebeiro, P. F., DʼSouza, G., Gill, M. J., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m21-0065 · Cited by 55
Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease
Bower, M., Veraitch, O. K., Szydlo, R., Charles, P., Kelleher, P., Gazzard, B., Nelson, M. R., & Stebbing, J. (2009) · Blood · doi:10.1182/blood-2008-12-197053 · Cited by 55
Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting
Wester, C. W., Koethe, J. R., Shepherd, B. E., Stinnette, S. E., Rebeiro, P. F., Kipp, A. M., Hong, H., Bussmann, H., Gaolathe, T., McGowan, C. C., et al. (2011) · AIDS · doi:10.1097/qad.0b013e328347f9d4 · Cited by 55
Subtypes of depressive symptoms and inflammatory biomarkers: An exploratory study on a sample of HIV-positive patients
Pala, A. N., Steca, P., Bagrodia, R., Helpman, L., Colangeli, V., Viale, P., & Wainberg, M. L. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.02.013 · Cited by 56
Plasma IL-6/IL-10 Ratio and IL-8, LDH, and HBDH Level Predict the Severity and the Risk of Death in AIDS Patients withPneumocystisPneumonia
Sun, J., Su, J., Xie, Y., Yin, M. T., Huang, Y., Xu, L., Zhou, Q., & Zhu, B. (2016) · Journal of Immunology Research · doi:10.1155/2016/1583951 · Cited by 55
Multimorbidity, age-related comorbidities and mortality
Duffau, P., Ozanne, A., Bonnet, F., Lazaro, E., Cazanave, C., Blanco, P., Rivière, É., Desclaux, A., Hyernard, C., Gensous, N., et al. (2018) · AIDS · doi:10.1097/qad.0000000000001875 · Cited by 56
A randomized, controlled trial of mindfulness-based stress reduction in HIV infection
Hecht, F. M., Moskowitz, J. T., Moran, P., Epel, E. S., Bacchetti, P., Acree, M., Kemeny, M. E., Mendes, W. B., Duncan, L. G., Weng, H., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.05.017 · Cited by 52
Coagulation and morbidity in treated HIV infection
Funderburg, N., & Lederman, M. M. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.03.012 · Cited by 54
Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers
Hatano, H., Somsouk, M., Sinclair, E., Harvill, K., Gilman, L. T., Cohen, M., Hoh, R., Hunt, P. W., Martin, J. N., Wong, J. K., et al. (2013) · AIDS · doi:10.1097/qad.0b013e328362692f · Cited by 54
Can early therapy reduce inflammation?
Utay, N. S., & Sereti, I. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000020 · Cited by 54
Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development
Keating, S. M., Jacobs, E. S., & Norris, P. J. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.05.006 · Cited by 52
Prognostic Value of Vitamin D Level for All-cause Mortality, and Association With Inflammatory Markers, in HIV-infected Persons
Shepherd, L. C., Souberbielle, J., Bastard, J., Fellahi, S., Capeau, J., Reekie, J., Reiss, P., Blaxhult, A., Bickel, M., Leen, C. L. S., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu074 · Cited by 55
Human Immunodeficiency Virus and Aging in the Era of Effective Antiretroviral Therapy
Epps, P. V., & Kalayjian, R. C. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.07.007 · Cited by 56
Learning From the Exceptions: HIV Remission in Post-treatment Controllers
Etemad, B., Esmaeilzadeh, E., & Li, J. Z. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01749 · Cited by 54
Focus on the heart: alcohol consumption, HIV infection, and cardiovascular disease.
Freiberg, M. S., & Kraemer, K. L. (2010) · Europe PMC (PubMed Central) · Cited by 53
Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy
Llibre, J. M., Arribas, J. R., Domingo, P., Gatell, J. M., Lozano, F., Santos, J. R., Rivero, A., Moreno, S., & Clotet, B. (2011) · AIDS · doi:10.1097/qad.0b013e3283499cd9 · Cited by 53
Lipid Metabolism in Treated HIV Infection
Dubé, M. P., & Cadden, J. J. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.04.004 · Cited by 53
Increased mucosal neutrophil survival is associated with altered microbiota in HIV infection
Hensley‐McBain, T., Wu, M. C., Manuzak, J. A., Cheu, R. K., Gustin, A. T., Driscoll, C. B., Zevin, A. S., Miller, C. J., Coronado, E., Smith, E. A., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007672 · Cited by 53
High-fat diet exacerbates SIV pathogenesis and accelerates disease progression
He, T., Xu, C., Krampe, N. A., Dillon, S. M., Sette, P., Falwell, E., Haret-Richter, G. S., Butterfield, T. R., Dunsmore, T., McFadden, W. M., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci121208 · Cited by 53
Changes in Causes of Death Among Persons with AIDS: San Francisco, California, 1996–2011
Schwarcz, S. K., Vu, A., Hsu, L. C., & Hessol, N. A. (2014) · AIDS Patient Care and STDs · doi:10.1089/apc.2014.0079 · Cited by 52
HIV RNA Suppression and Immune Restoration: Can We Do Better?
Pinzone, M. R., Rosa, M. D., Cacopardo, B. S., & Nunnari, G. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/515962 · Cited by 52
Chronic HIV disease and activation of the coagulation system
Baker, J. V. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.08.016 · Cited by 52
Elevated Biomarkers of Inflammation and Coagulation in Patients with HIV Are Associated with Higher Framingham and VACS Risk Index Scores
Mooney, S., Tracy, R. P., Osler, T. M., & Grace, C. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144312 · Cited by 52
The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy
Koethe, J. R., Grome, H. N., Jenkins, C. A., Kalams, S. A., & Sterling, T. R. (2015) · AIDS · doi:10.1097/qad.0000000000000893 · Cited by 55
Activated platelet–T-cell conjugates in peripheral blood of patients with HIV infection
Green, S. A., Smith, M., Hasley, R. B., Stephany, D., Harned, A., Nagashima, K., Abdullah, S. A. A., Pittaluga, S., Imamichi, T., Qin, J., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000701 · Cited by 55
Clinical trials of antiretroviral treatment interruption in HIV-infected individuals
Lau, J. S. Y., Smith, M. Z., Lewin, S. R., & McMahon, J. H. (2018) · AIDS · doi:10.1097/qad.0000000000002113 · Cited by 52
The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms
Baker, J. V., Henry, W. K., & Neaton, J. D. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328329c62f · Cited by 52
Correlates of Elevated Interleukin-6 and C-Reactive Protein in Persons With or at High Risk for HCV and HIV Infections
Salter, M. L., Lau, B. M., Mehta, S. H., Go, V. F.-L., Leng, S. X., & Kirk, G. D. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182a7ee2e · Cited by 51
Plasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals
French, M. A., Cozzi‐Lepri, A., Arduino, R. C., Johnson, M. A., Achhra, A. C., & LANDAY, A. L. (2015) · AIDS · doi:10.1097/qad.0000000000000618 · Cited by 51
Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus
Moreno, J. A., Beltrán, L. M., Rubio‐Navarro, A., Puig, J. G., Amaro-Villalobos, J. M., & Egido, J. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s65885 · Cited by 54
Statin Therapy Decreases Serum Levels of High-Sensitivity C-Reactive Protein and Tumor Necrosis Factor-α in HIV-Infected Patients Treated With Ritonavir-Boosted Protease Inhibitors
Calza, L., Trapani, F., Bartoletti, M., Manfredi, R., Colangeli, V., Borderi, M., Grossi, G., Motta, R., & Viale, P. (2012) · HIV Clinical Trials · doi:10.1310/hct1303-153 · Cited by 51
18FDG PET-CT imaging detects arterial inflammation and early atherosclerosis in HIV-infected adults with cardiovascular disease risk factors
Yarasheski, K. E., Laciny, E., Overton, E. T., Reeds, D. N., Harrod, M., Baldwin, S., & Dávila‐Román, V. G. (2012) · Journal of Inflammation · doi:10.1186/1476-9255-9-26 · Cited by 51
The Changing Epidemiology of HIV-Infected Patients in the Intensive Care Unit
Akgün, K. M., Pisani, M. A., & Crothers, K. A. (2011) · Journal of Intensive Care Medicine · doi:10.1177/0885066610387996 · Cited by 50
Obesity is associated with greater inflammation and monocyte activation among HIV-infected adults receiving antiretroviral therapy
Conley, L. J., Bush, T. J., Rupert, A. W., Sereti, I., Patel, P., Brooks, J. T., & Baker, J. V. (2015) · AIDS · doi:10.1097/qad.0000000000000817 · Cited by 51
How elite controllers and posttreatment controllers inform our search for an HIV-1 cure
Li, J. Z., & Blankson, J. N. (2021) · Journal of Clinical Investigation · doi:10.1172/jci149414 · Cited by 51
Interruption of antiretroviral therapy is associated with increased plasma cystatin C
Mocroft, A., Wyatt, C. M., Szczech, L. A. M., Neuhaus, J., El-Sadr, W. M., Tracy, R. P., Kuller, L. H., Shlipak, M. G., Angus, B., Klinker, H., et al. (2008) · AIDS · doi:10.1097/qad.0b013e32831cc129 · Cited by 51

Authors: Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., Paton, N. I., Neaton, J. D., & for the INSIGHT SMART Study Group
Affiliations: University of Pittsburgh (US)
University of Vermont (US)
Hospital Italiano de Buenos Aires (AR)
UNSW Sydney (AU)
National Institutes of Health (US)
University Hospital Zurich (CH)
University of Copenhagen (DK)
University of Minnesota (US)
Virginia Commonwealth University (US)
Medical Research Council (GB)
Corresponding author: Neaton, James D
ORCID: Kuller, Lewis H
Tracy, Russell
Belloso, Waldo
Drummond, Fraser
Lane, H. Clifford
Ledergerber, Bruno
Lundgren, Jens
Paton, Nicholas I
Neaton, James D
Venue: PLoS Medicine
Publisher: Public Library of Science (PLoS)
Published: 2008-10-21
Volume: 5
Issue: 10
Pages: e203
ISSN: 1549-1277 (ISSN-L)
1549-1676
DOI: 10.1371/journal.pmed.0050203
PMC: PMC2570418
OpenAlex: W2153136696
Cited by: 1,617
References: 42
Citations by year: 2026: 40 · 2025: 42 · 2024: 57 · 2023: 56 · 2022: 70 · 2021: 77 · 2020: 98 · 2019: 82 · 2018: 105 · 2017: 86 · 2016: 120 · 2015: 129 · 2014: 146 · 2013: 142 · 2012: 118
FWCI: 53.14
Type: journal article
Language: en
Open access: gold
doi.org
Licence: public-domain
creativecommons.org/publicdomain/zero/1.0/ (unspecified)
Locations: PLoS Medicine (publishedVersion, public-domain)
PubMed Central (publishedVersion, public-domain)
PubMed (publishedVersion)
Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (publishedVersion, cc-by)
Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
D-Scholarship@Pitt (University of Pittsburgh) (acceptedVersion)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, cc-by)
National University of Singapore (submittedVersion)
VCU Scholars Compass (Virginia Commonwealth University) (submittedVersion, public-domain)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Figshare (submittedVersion, cc-by)
RECERCAT (Consorci de Serveis Universitaris de Catalunya) (submittedVersion, cc-by)
Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
Zurich Open Repository and Archive (University of Zurich)
Funders: Bristol-Myers Squibb
Pfizer
GlaxoSmithKline
Gilead Sciences
Wake Forest University
Johns Hopkins University
National Institutes of Health
National Institute of Allergy and Infectious Diseases (U01 AI46362, U01AI046362, U01AI042170)
Topics: Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Keywords: HIV infection, all-cause mortality, inflammatory markers, coagulation markers, C-reactive protein, interleukin-6, D-dimer, prothrombin fragment 1+2, amyloid A, antiretroviral therapy interruption, viral rebound, thrombosis, fibrinolysis, tissue factor
MeSH terms: Serum Amyloid P-Component, Serum Amyloid A Protein, Blood Coagulation, C-Reactive Protein, Cause of Death, Female, Fibrin Fibrinogen Degradation Products, Follow-Up Studies, Humans, Inflammation, Male, Multicenter Studies as Topic, Biomarkers, HIV Infections, Interleukin-6, Survival Rate, Logistic Models, Odds Ratio, Case-Control Studies, Randomized Controlled Trials as Topic, Treatment Outcome, Anti-HIV Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks